CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Unsecured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Unsecured Loans | - | - | ₹-332 Cr | ₹40 Cr | ₹847 Cr |
What is the latest Unsecured Loans ratio of CIPLA ?
| Year | Unsecured Loans |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹-332 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹847 Cr |
How is Unsecured Loans of CIPLA Trending?
| Years | Unsecured Loans | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 100.00 | |
| Mar2023 | ₹-332 Cr | Negative | |
| Mar2022 | ₹40 Cr | -95.28 | |
| Mar2021 | ₹847 Cr | - | |
Compare Unsecured Loans of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹106,213.6 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
| MANKIND PHARMA | ₹86,802.6 Cr | -0.7% | -5.7% | -20.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -5.5% |
-12.4% |
-5.1% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses